A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia who are not Candidates for Intensive Chemotherapy.

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

StatusActive
Effective start/end date22/10/19 → 31/12/24
View all
View less

Keywords

  • Malignant Haematology
  • Acute Myeloid Leukaemia (AML)
  • Clinical Trial